1. Home
  2. SHOO vs IRON Comparison

SHOO vs IRON Comparison

Compare SHOO & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Steven Madden Ltd.

SHOO

Steven Madden Ltd.

HOLD

Current Price

$36.53

Market Cap

3.3B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$73.54

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHOO
IRON
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
SHOO
IRON
Price
$36.53
$73.54
Analyst Decision
Buy
Strong Buy
Analyst Count
8
12
Target Price
$42.75
$110.08
AVG Volume (30 Days)
1.6M
526.7K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
2.35%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
$2,362,727,000.00
N/A
Revenue This Year
$13.06
N/A
Revenue Next Year
$12.67
N/A
P/E Ratio
$45.72
N/A
Revenue Growth
6.41
N/A
52 Week Low
$19.05
$30.82
52 Week High
$46.88
$99.50

Technical Indicators

Market Signals
Indicator
SHOO
IRON
Relative Strength Index (RSI) 33.10 41.49
Support Level $33.89 $76.00
Resistance Level $46.88 $83.93
Average True Range (ATR) 2.13 4.20
MACD -1.16 0.20
Stochastic Oscillator 20.63 13.69

Price Performance

Historical Comparison
SHOO
IRON

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: